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Maternal microchimerism (mMc) refers to the presence of a small population of cells originating from the mother. Whether mMc
leads to autoimmune responses in children remains controversial. We describe here an 11-year-old boy with persistent fever and
elevated levels of C-reactive protein from infancy onward. During infancy, the patient presented with high fever, skin rashes, and
hepatic dysfunction. Careful examination including a liver biopsy failed to reveal the cause. At 4 years old, petechiae developed
associated with thrombocytopenia and positive anti-dsDNA autoantibodies. Steroid pulse therapy was eﬀective, but the eﬀect
of low-dose prednisone was insuﬃcient. At age 9, an extensive diﬀerential diagnosis was considered especially for infantile onset
autoinﬂammatory disorders but failed to make a deﬁnitive diagnosis. On admission, the patient exhibited short stature, hepato-
splenomegaly,generalizedsuperﬁciallymphadenopathy,andrashes.Laboratoryﬁndingsrevealedanemia,elevatedlevelsofinﬂam-
mation markers, and hypergammaglobulinemia. Serum complement levels were normal. Serum levels of IL-6 and B-cell activating
factor were elevated. Viral infections were not identiﬁed. Although HLA typing revealed no noninherited maternal antigens
in lymphocytes, female cells were demonstrated in the patient’s skin and lymph nodes, suggesting that maternal microchimerism
might be involved in the pathogenesis of fever without source in infants.
1.Introduction
Maternal microchimerism (mMc) refers to the presence of a
small population of cells originating from the mother. Sev-
eral reports have documented that maternal microchimeric
cells may be involved in the pathogenesis of some autoim-
munediseasesinchildrensuchasneonatallupus[1],juvenile
dermatomyositis [2], biliary atresia [3], and type 1 diabetes
[4], whereas mMc may persist into adulthood without any
symptoms in individuals with normal immune systems
[5]. Thus, whether mMc leads to autoimmune diseases in
children remains controversial [6]. Since chimerism after
allogeneic HLA-mismatched stem cell transplantation can
cause chronic inﬂammation, that is, chronic graft versus
host disease (cGVHD), mMc might trigger cGVHD-like
symptoms [7]. We describe a boy who had recurrent fever
without source since early infancy and which was associated
with mMc.
2. Case Presentation
An 11-year-old boy was admitted for biopsy of a skin rash
and an enlarged axillary lymph node. No family history
of autoimmune disease or autoinﬂammatory disorder was
evident, and he had received no blood transfusion or stem
cell transplantation. The patient had suﬀered from recurrent
fever since infancy. At one-month old, the patient presented
with fever without source, maculopapular rashes, and poor
weight gain. Laboratory examinations revealed elevated
levels of liver enzymes and C-reactive protein (CRP). Despite
a careful examination, however, neither infection nor neo-
plasm was detected. There was also no evidence of biliary
disorder.Asthepatientwaswellfedandhisgeneralcondition
was not much aﬀected, he was followed closely as an
outpatient, without therapy. Liver biopsy at seven-month
old demonstrates features of chronic active hepatitis, with
lymphocyte and plasma cell inﬁltration in Glisson’s capsule2 Case Reports in Pediatrics
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Figure 1: Fluorescence in situ hybridization analysis: maternal XX karyotype cells (arrowed lines/two green dots) among XY cells
(arrowheads/red and green dots) in the skin (a) and lymph node (b).
yet without ﬁbrosis and with a diﬀuse hepatocyte ballooning
pattern.
Primary immunodeﬁciencies including phagocyte dis-
orders, antibody deﬁciencies, complement deﬁciencies, and
combinedT-andB-cellimmunodeﬁciencies[8]wer er efuted
through further examinations. Liver markers gradually nor-
malized by age 3, whereas CRP levels remained elevated,
and skin rash and fever without source relapsed occasionally.
This long-standing fever and elevation of CRP levels without
infection or neoplasm were considered possible indicators
of autoimmune disease. However, as laboratory ﬁndings
supporting the diagnosis of autoimmune disease such as
positive antinuclear antibody test were not obtained, a def-
inite diagnosis could not be established. At age 4, petechiae
developed on the trunk, associated with thrombocytopenia
and positive anti-dsDNA autoantibodies. Intravenous pulse
steroid therapy was administered and this ameliorated both
the clinical and laboratory ﬁndings. Petechiae and purpura
disappeared and remittent fever resolved. Platelet count
increasedwithinnormalrangeandCRPturnednegative.The
elevation of anti-dsDNA autoantibodies diminished within
normal limits at this time. Nevertheless, CRP level rose
again soon afterwards. Low-dose oral prednisone (5mg/day)
was commenced, but high-dose prednisone was frequently
required when high fever developed. Frequent exacerbations
and remissions of erythematous rash were observed all the
while. At age 7, investigations for short stature revealed
growthhormone(GH)deﬁciency,andGHreplacementther-
apy was started but showed little eﬀect. At age 9, an extensive
diﬀerential diagnosis was considered for primary immunod-
eﬁciencies, especially infantile onset autoinﬂammatory dis-
orders[9,10]withclinicalmanifestationsevenifonlyslightly
consistent with those observed in the patient. This involved
genetic testing for conditions including cryopyrin-associated
periodic syndrome (C1AS1), familial Mediterranean fever
(MEFV), tumor necrosis factor receptor-associated periodic
syndrome (TNFRSF1A), and hyper-IgD syndrome (MVK).
However, none of these genetic defects was identiﬁed. Innate
immunity deﬁciencies were excluded as clinical symptoms of
thispatientwerenotconsistentwiththoseofdefectsofinnate
immunity currently known. The similarity of the patient’s
clinical course and laboratory ﬁndings to those of cGVHD
suggested the stable long-term persistence of allogenic cells,
that is, mMc. Throughout the course, we observed that
persistent fever and elevated CRP often resolved, contrary to
expectations, when the patient had symptoms of an upper
respiratorytractinfection.Foradeﬁnitivediagnosis,abiopsy
of the skin and lymph node lesions was planned.
On admission, the patient exhibited markedly short
stature (−5.5SD) unresponsive to GH treatment, hep-
atosplenomegaly, generalized superﬁcial lymphadenopathy,
and urticaria-like rashes. No arthropathy was observed.
Laboratory ﬁndings revealed anemia (Hb 8.2g/dL), elevated
levelsofinﬂammationmarkerssuchasCRP,ESR(79mm/h),
and SAA (563μg/dL), and hypergammaglobulinemia (IgG
3721mg/dL). Serum complement levels were normal. Serum
levels of IL-6 and B-cell activating factor (BAFF) were
elevated at 21.4pg/L and 3314pg/mL, respectively. Viral
infections such as Epstein-Barr virus, cytomegalovirus, and
parvovirus B19 were not identiﬁed. Ophthalmologic exami-
nation was unremarkable. Thoracoabdominal CT scan
showed hepatosplenomegaly and mild systemic lympha-
denopathy.Galliumscintigraphyrevealednoabnormalaccu-
mulation. Bone marrow examination revealed no abnormal-
ity. Histological examination of the skin revealed nonspe-
ciﬁc inﬂammation. The perivascular and periappendicular
mononuclear inﬁltration was observed in dermis. That of
lymph node showed no increase of plasma cells but of histio-
cytesanddendriticcells.Epstein-BarrvirusDNAandhuman
herpes virus type 8 DNA were not detected.
HLA typing using nested polymerase chain reaction
(PCR) with sequence-speciﬁc primer typing revealed nonin-
herited maternal antigens below measurable limits (<0.01%)
in circulating lymphocytes. On the other hand, female cells
were demonstrated in the patient’s skin and lymph nodes
by ﬂuorescence in situ hybridization labeling for the X and
Y chromosomes (Figure 1). The percentage of female cells,
presumed maternal, was 0.2% of all nuclei examined in the
skin and 0.3% of those in the lymph node. Since elevated
IL-6 was thought to be important in the pathogenesis,
tocilizumab therapy was started. After the ﬁrst tocilizumab
infusion, IL-6 level rose further to 2230pg/L as expected.
Fever resolved, and the levels of CRP and BAFF normalized
shortly thereafter. IL-6 level decreased but remained elevatedCase Reports in Pediatrics 3
(approximately 200pg/L). The patient’s height did not
increase signiﬁcantly, and the skin lesions persisted after
more than 100 infusions.
3. Discussion
We present a patient with recurrent fever without source
who posed a diagnostic challenge. Based on the clinical and
laboratory ﬁndings, primary immunodeﬁciencies and auto-
immune and autoinﬂammatory diseases had been consid-
ered in the diﬀerential diagnosis, but we had failed to make
a deﬁnite diagnosis. The similarity of the aﬀected lesions
between this patient and those with cGVHD provided a
clue to the involvement of mMc in the clinical condition.
Although mMc exists even in normal individuals and the
possibility of unknown autoinﬂammatory mechanisms was
not entirely ruled out, several observations suggested the
involvement of mMc in the etiology of this patient’s under-
lying condition. First, quantitative analysis of micro-
chimerism revealed female cells in the skin and lymph node
lesions but not in the blood cells, suggesting the tissue-
speciﬁc survival of maternal chimeric cells. In autoimmune
diseases associated with microchimerism, patients with a
high number of chimeric cells would be prone to enhanced
immune response [11]. In the present case, the frequency
of microchimeric cells was considered high, given that this
has been documented at 0.05% in the skin of male infants at
autopsy [12]. Secondly, BAFF level was much higher in this
patient before tocilizumab infusions than those previously
determined in healthy children [13]. Markedly elevated
BAFF levels contribute to B-cell activation in patients with
active cGVHD, which results in speciﬁc abnormalities of B-
cell homeostasis [14, 15]. Thirdly, the change of the target of
immune response from ever-present chimeric cells to foreign
pathogen might be accountable for the resolution of fever
and elevated CRP level during infectious diseases such as
upper respiratory tract infections. Furthermore, the elevated
levels of IL-6 in this patient were consistent with those in
cGVHD [16, 17]. The rapid elevation of IL-6 levels after
the ﬁrst tocilizumab infusion in this patient also accords
with previous observations [18]. As tocilizumab competes
with IL-6 for its receptors, free IL-6 increases after infused
tocilizumab occupied IL-6 receptors. Considering that free
IL-6 level has not reached normal range in the present
patient, however, mild inﬂammation might still be present.
In conclusion, the present case suggested that tissue-
speciﬁc microchimerism in which maternal cells diﬀerenti-
atedinsituwithinfetalorganscouldbecomethetargetforan
autoimmune response and that tocilizumab can be eﬀective
for the symptoms associated with mMc. Our experience
suggests that when the origin of prolonged fever is unknown
even after detailed examination, clinicians should be aware
of the possible involvement of maternal microchimerism.
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